| Database ID | Symbol | Category | Cancer Type | CTC Isolation Method | Dataset | Detail |
|---|
| BRCA64089 | AP003031.1 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64090 | AP001372.2 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64092 | SCARNA9 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64093 | AP001318.3 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64094 | AP002360.2 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64095 | AP001636.3 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64096 | AP001267.3 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64097 | AP002812.5 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64098 | AP001767.3 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64099 | AP003031.2 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64100 | MIR9-3HG | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64101 | AGAP2-AS1 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64102 | AC117503.2 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64104 | URB1-AS1 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |
| BRCA64106 | AP001453.2 | lncRNA | breast cancer | microfluidics immunofluorescence | GSE109761 | Detail |